BTK Inhibitors in CLL: New Clinical Evidence Reshapes First-Line Treatment Check back later for a possible video summary. Videos are created for most articles. Introduction The treatment landscape for chronic lymphocytic leukemia (CLL), the most common leukemia in Western countries, has undergone a major shift with the advent of Bruton’s tyrosine kinase (BTK) inhibitors. These
Tag: BTK inhibitor
